Romiplostim (AMG-531)

DRUG2 trials

Sponsors

Kyowa Kirin Co., Ltd., Children's Hospital Medical Center, Cincinnati

Conditions

Chemotherapy Induced ThrombocytopeniaEwings SarcomaThrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Early Phase 1

Single Arm Romiplostim to Prevent CIT

RecruitingNCT07048249

Children's Hospital Medical Center, CincinnatiChemotherapy Induced Thrombocytopenia, Ewings Sarcoma

Start: 2024-01-26End: 2028-01-01Target: 26Updated: 2026-03-18

Phase 2

Safety Study of AMG 531 in Japanese Subjects With ITP

CompletedNCT00305435

Kyowa Kirin Co., Ltd.Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Start: 2006-02-28End: 2006-11-30Updated: 2024-07-05